A randomized, multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)
Abstract only LBA4000 The full, final text of this abstract will be available at abstract.asco.org at 12:01 AM (EDT) on Saturday, June 2, 2012, and in the Annual Meeting Proceedings online supplement to the June 20, 2012, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract wi...
Saved in:
Published in | Journal of clinical oncology Vol. 30; no. 15_suppl; p. LBA4000 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
20.05.2012
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract only
LBA4000
The full, final text of this abstract will be available at abstract.asco.org at 12:01 AM (EDT) on Saturday, June 2, 2012, and in the Annual Meeting Proceedings online supplement to the June 20, 2012, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News. |
---|---|
ISSN: | 0732-183X 1527-7755 |
DOI: | 10.1200/jco.2012.30.15_suppl.lba4000 |